Söndag 23 Februari | 22:30:50 Europe / Stockholm

Prenumeration

2025-02-13 11:47:00

Redeye provides an update following Neola Medical’s Q4 2024 report. The report aligned with our expectations, and we look forward to an important 2025, including clinical validation of the Neola device. We make some model adjustments based on the report, rendering an updated fair value range.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/